期刊文献+

补体C3d-p28增强阿尔茨海默病DNA疫苗Th2型免疫反应的研究 被引量:2

Enhancement of Th2 Immune Response to Alzheimer's disease DNA Vaccine by complement C3d-p28
下载PDF
导出
摘要 目的 探讨补体C3d-p28作为分子佐剂,在阿尔茨海默病DNA疫苗免疫反应中的作用。方法 分别将重组质粒p(Aβ3-10)10,p(Aβ3-10)10-C3d-p28.3和空载体pc DNA3.1(+)用肌肉注射的方法免疫8-10周龄的雌性BALB/c鼠。质粒注射前24 h,布比卡因肌肉注射诱导轻微的肌肉变性。应用ELISA方法检测血清抗Aβ抗体的滴度、抗体分型、体外脾细胞培养上清液中IL-4和IFN-γ的含量。免疫组织化学染色法检测免疫血清与转基因鼠脑内Aβ斑的结合能力。结果 重组质粒疫苗p(Aβ3-10)10仅诱导出低滴度的抗Aβ抗体,产生了Th1/Th2混合型的免疫反应。而重组质粒疫苗p(Aβ3-10)10-C3d-p28.3诱导出较高滴度的抗Aβ抗体,体外脾细胞培养上清液中IFN-γ低和IL-4高,即引起了Th2型细胞免疫反应,同时产生的抗Aβ抗体能够与双转基因鼠APP/PS1脑中沉积的Aβ斑块结合。结论 补体C3d-p28分子佐剂能够增强抗Aβ抗体的产生并且诱发Th2型的免疫反应。 Objective To discuss the effect of complement C 3d-p28 in the immune response of Alzheimer DNA vac-cine bstract.Methods Eight to ten week-old female BALB/c mice were immunized intramuscularly with recombinant plasmid p(Aβ3-10)10,p(Aβ3-10)10-C3d-p28.3 and pcDNA3.1( +).24 h prior to plasmid injection,bupivacaine was injected to induce mild muscle degeneration .ELISA was used to detect the titer of serum anti-Aβantibody ,isotypes of im-munoglobulin and levels of IL-4 and IFN-γin ex vivo splenocyte culture supernatants .Immunohistochemistry was used to detect the binding capability of antisera to Aβplaques in an APP/PS1 transgenic mouse brain .Results We have success-fully constructed two plasmid DNA vaccines:p(Aβ3-10)10 expressing ten repeats of Aβ3-10 without adjuvant and p(Aβ3-10)10-C3d-p28.3 encoding ten repeats of Aβ3-10 and three copies of C3d-p28 as a molecular adjuvant .Immunization of eight to ten week-old female BALB/c mice with p(Aβ3-10)10 vaccine induced only moderate titers of anti-amyloid-βanti-bodies and elicited a Th1/Th2 immune response.However,adding of the C3d-p28 molecular adjuvant to Aβ3-10 DNA vac-cine could generate high levels of anti-amyloid-βantibodies (P〈0.05) which bound to Aβplaques in APP/PS1 transgenic mouse brain tissue.More importantly,the vaccine elicited a predominantly IgG1 humoral response (P〈0.05),low levels of IFN-γ(P〈0.05) and high levels of IL-4 in ex vivo cultured splenocytes (P〈0.05),indicating a Th2-polarized cellular immune response.Conclusion Complement C3d-p28 molecular adjuvant enhances anti-amyloid-βantibody generation and induces a Th2-polarized immune response .
出处 《中风与神经疾病杂志》 CAS 北大核心 2016年第11期976-979,共4页 Journal of Apoplexy and Nervous Diseases
关键词 阿尔茨海默病 Β淀粉样蛋白 DNA疫苗 C3d-p28分子佐剂 Alzheimer’s disease DNA vaccine C3d-p28 molecular adjuvant
  • 相关文献

参考文献1

二级参考文献31

  • 1Dempsey PW, Allison MED, Akkaraju S, Goodnow CC, Fearon DT. C3d of complement as a molecular adjuvant: bridging innate and acquired immunity. Science 1996; 271:348-350.
  • 2Test ST, Mitsuyoshi J, Connelly CC, Lucas AH. Increased immunogenicity and induction of class switching by conjugation of complement C3d to pneumococcal serotype 14 capsular polysaccharide. Infect Immun 2001; 69:3031-3040.
  • 3Ross TM, Xu Y, Green TD, Montefiori DC, Robinson HL. Enhanced avidity maturation of antibody to human immunodeficiency virus envelope: DNA vaccination with gp120-C3d fusion proteins. AIDS Res Hum Retroviruses 2001; 17:829-835.
  • 4Green TD, Newton BP, Rota PA, Xu Y, Robinson HL, Ross TM.C3d enhancement of neutralizing antibodies to measles hemagglutinin. Vaccine 2001; 20- 242-248.
  • 5Tew JG, Wu J, Qin D, Helm S, Burton GF, Szakal AK. Follicular dendritic cells and presentation of antigen and costimulatory signals to B cells. Immunol Rev 1997; 156:39-52.
  • 6Yellin MJ, Sinning J, Covey LR, Sherman W, Lee JJ, Glickman-Nir E, Sippel KC, Rogers J, Cleary AM, Parker M, Chess L,Lederman S. T lymphocyte T cell-B cell-activating molecule/CD40-L molecules induce normal B ceils or chronic lymphocytic leukemia B cells to express CD80 (B7/BB-1) and enhance their costimulatory activity.J Immunol 1994; 153:666-674.
  • 7Lambris JD, Ganu VS, Hirani S, MiJller-Eberhard HJ. Mapping of the C3d receptor (CR2)-binding site and a neoantigenic site in the C3d domain of the third component of complement. Proc Natl Acad Sci U S A 1985; 82:4235-4239.
  • 8Esparza I, Becherer JD, Alsenz J, De la Hera A, Lao Z, Tsoukas CD, Lambris JD. Evidence for multiple sites of interaction in C3 for complement receptor type 2 (C3d/EBV receptor, CD21). Eur J Immunol 1991; 21:2829-2838.
  • 9Servis C, Lambris JD. C3 synthetic peptides support growth of human CR2-positive lymphoblastoid B cells. J Immuno11989; 142:2207-2212.
  • 10Frade R, Hermarm J, Barel M. A 16 amino acid synthetic peptide derived from human C3d triggers proliferation and specific tyrosine phosphorylation of transformed CR2-positive human lymphocytes and of normal resting lymphocytes-B. Biochem Biophys Res Commun 1992; 188:833-842.

共引文献3

同被引文献3

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部